tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
INMB is currently covered by 1 analysts with an average price target of $9. This is a potential upside of $7.66 (287.93%) from yesterday's end of day stock price of $2.32.
INmune Bio's activity chart (see below) currently has 17 price targets and 20 ratings on display. The stock rating distribution of INMB is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 33.93% with an average time for these price targets to be met of 128.57 days.
Highest price target for INMB is $9, Lowest price target is $9, average price target is $9.
Most recent stock forecast was given by from LUCID CAPITAL on 11-Mar-2026. First documented stock forecast 19-Mar-2019.
Currently out of the existing stock ratings of INMB, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 11-Mar-2026
$9
$7.58 (533.80%)
$2
Buy Since 19-Mar-2019
$8
$6.58 (463.38%)
$30
Buy Since 22-Aug-2024
$0.6
$-0.82 (-57.75%)
$23
What is INMB (INmune Bio) average time for price targets to be met?
Which analyst has the current highest performing score on INMB (INmune Bio) with a proven track record?
Which analyst has the most public recommendations on INMB (INmune Bio)?
Which analyst is the currently most bullish on INMB (INmune Bio)?
Which analyst is the currently most reserved on INMB (INmune Bio)?
